Coagulation factor concentrate-based therapy for remote damage control resuscitation (RDCR): A reasonable alternative?

Transfusion

Volumn 56, Issue , 2016, Pages S157-S165

  Maegele, Marc ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR CONCENTRATE; FIBRINOGEN; HEMOSTATIC AGENT; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ARTICLE; BLEEDING; BLOOD CLOTTING; FIBRINOLYSIS; HEMOSTASIS; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HUMAN; POINT OF CARE TESTING; REMOTE DAMAGE CONTROL RESUSCITATION; RESUSCITATION; THROMBOELASTOGRAPH; EMERGENCY HEALTH SERVICE; HEMORRHAGE; PROCEDURES; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION FACTORS; EMERGENCY MEDICAL SERVICES; HEMORRHAGE; HUMANS; PROSPECTIVE STUDIES; RESUSCITATION; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84964330972     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13526     Document Type: Article

References (86)

1. Teixeira P, Inaba K, Hadjizacharia P, et al., Preventable or potentially preventable mortality in a mature trauma center. J Trauma 2007; 63: 1338-47.
2. Kauvar D, Lefering R, Wade C., Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006; 60: S3-11.
3. Ball CG., Damage control resuscitation: history, theory and technique. Can J Surg 2014; 57: 55-60.
4. Holcomb JB, Jenkins D, Rhee P, et al., Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62: 307-10.
5. Mitra B, O'Reilly O, Cameron P, et al., Effectiveness of massive transfusion protocols on mortality in trauma: a systematic review and meta-analysis. ANZ J Surg 2013; 83: 918-23.
6. Holcomb J, Tilley BC, Baraniuk S, et al., Transfusion of plasma, platelets and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma. JAMA 2015; 313: 471-82.
7. Pidcoke H, Aden J, Mora A, et al., Ten-year analysis of transfusion in operation Iraqi freedom and operation enduring freedom. J Trauma Acute Care Surg 2012; 73: S445-52.
8. Cotton B, Au B, Nunez T, et al., Predefined massive transfusion protocols are associated with a reduction in organ failure and postoperative complications. J Trauma 2009; 66: 41-8.
9. Holcomb J, Wade C, Michalek J, et al., Increased plasma and platelet to red blood cell ratios improve outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248: 447-58.
10. Del Junco D, Holcomb J, Fox E, et al., Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg 2013; 75: S24-30.
11. Solomon C, Traintinger S, Ziegler B, et al., Platelet function following trauma: a multiple electrode aggregometry study. Thromb Haemost 2011; 106: 322-30.
12. Kutcher M, Redick B, McCreery R, et al., Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg 2012; 73: 13-9.
13. Windelov N, Sorensen A, Perner A, et al., Platelet aggregation following trauma. Blood Coagul Fibrinolysis 2014; 25: 67-73.
14. Peiniger S, Paffrath T, Mutschler M, et al., The trauma patient in hemorrhagic shock: how is the C-priority addressed between emergency and ICU admission? Scand J Trauma Resusc Emerg Med 2012; 20: 78.
15. Jenkins DH, Rappold JF, Badloe JF, et al., Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice, and knowledge gaps. Shock 2014; 41: 3-12.
16. Gerhardt RT, Berry JA, Blackbourne LH., Analysis of life-saving interventions performed by out-of-hospital combat medical personnel. J Trauma 2011; 71: S109-13.
17. Strandenes G, Spinella PC., The Solstrand remote damage control resuscitation symposium. Transfusion 2013; 53: 6S-8S.
18. Gerhardt RT, Strandenes G, Cap AP, et al., Remote damage control resuscitation and the Solstrand conference: defining the need, the language, and a way forward. Transfusion 2013; 53: 9S-16S.
19. Yonge J, Schreiber M., The pragmatic randomized optimal platelet and plasma ratios trial: what does it mean for remote damage control resuscitation? Transfusion 2015.
20. Jenkins D, Stubbs J, Williams S, et al., Implementation and execution of civilian remote damage control resuscitation programs. Shock 2014; 41: 84-9.
21. Sunde G, Vikenes B, Strandenes G, et al., Freeze dried plasma and fresh red blood cells for civilian pre-hospital hemorrhagic shock resuscitation. J Trauma Acute Care Surg 2015; 78: S26-30.
22. Bux J, Dickhorner D, Scheel E., Quality of freeze-dried plasma (lyophilized) plasma quarantined single-donor plasma. Transfusion 2013; 53: 3203-9.
23. Martinaud C, Ausset S, Deshayes AV, et al., Use of freeze-dried plasma in French intensive care unit in Afghanistan. J Trauma 2011; 71: 1761-4.
24. Apodaca A, Olson C, Bailey F, et al., Performance improvement evaluation of forward aeromedical evacuation platforms in operation enduring freedom. J Trauma Acute Care Surg 2013; 75: S157-63.
25. Spinella P, Strandenes G, Hervig T, et al., Whole blood for hemostatic resuscitation of major bleeding. Transfusion 2015.
26. Stubbs J, Zielinski M, Jenkins D., The state of the science of whole blood: lessons learned at the Majo clinic. Transfusion 2015.
27. Schöchl H, Maegele M, Voelkel W., Fixed ratio versus goal-directed therapy in trauma. Curr Opin Anaesthesiol 2015. doi:10:1097/ACO.0000000000000278.
28. Hallet J, Lauzier F, Mailloux O, et al., The use of higher platelet: RBC transfusion ratio in the acute phase of trauma resuscitation: a systematic review. Crit Care Med 2013; 41: 2800-11.
29. Ponschab M, Schlimp CJ, Zipperle J, et al., Platelet function in reconstituted whole blood variants: an observational study over 5 days of storage time. J Trauma Acute Care Surg 2015; 79: 797-804.
30. Cushing M, Shaz BH., Blood transfusion in trauma patients: unresolved questions. Minerva Anestesiol 2011; 77: 349-59.
31. Nascimiento B, Callum J, Tien H, et al., Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ 2013; 185: E583-9.
32. Inaba K, Branco BC, Rhee P, et al., Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010; 210: 957-65.
33. Sambasivan CN, Kunio NR, Nair PV, et al., High ratios of plasma and platelets to packed red blood cells do not affect mortality in nonmassively transfused patients. J Trauma 2011; 71: S329-36.
34. Borgman MA, Spinella PC, Holcomb JB, et al., The effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction score. Vox Sang 2011; 101: 44-5.
35. Hess JR., Resuscitation of trauma-induced coagulopathy. Hematology Am Soc Hematol Educ Program 2013; 2013: 664-7.
36. Ponschab M, Schöchl H, Gabriel C, et al., Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations. Anaesthesia 2015; 70: 528-36.
37. Khan S, Davenport R, Raza I, et al., Damage control resuscitation using component therapy in standard doses has limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med 2015; 41: 239-47.
38. Khan S, Brohi K, Chana M, et al., Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg 2014; 76: 561-71.
39. BÄK (Bundesärztekammer) 2009 Querschnittsleitlinien der BÄK zur Therapie mit Blutkomponenten und Plasmaderivaten. 4 Auflage. http:///www.bundesaerztekam-mer.de
40. Schöchl H, Nienaber U, Hofer G, et al., Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55.
41. Schöchl H, Maegele M, Solomon C, et al., Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012; 20: 15.
42. Nienaber U, Innerhofer P, Westermann I, et al., The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011; 42: 697-701.
43. Schöchl H, Voelckel W, Maegele M, et al., Trauma-associated hyperfibrinolysis. Hamostaseologie 2012; 32: 22-7.
44. Raza I, Davenport R, Rourke C, et al., The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11: 307-14.
45. CRASH-2 Collaborators, Roberts I, Shakur H, et al., The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis on the CRASH-2 randomised controlled trial. Lancet 2011; 26:377: 1096-101.
46. Roberts I., Tranexamic acid in trauma: how should we use it? J Thromb Haemost 2015; 13: S195-9.
47. Ives C, Inaba K, Branco BC, et al., Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg 2012; 215: 496-502.
48. Spahn DR, Bouillon B, Cerny V, et al., Management of bleeding and coagulopathy following major trauma: an up-dated European guideline. Crit Care 2013; 17: R76.
49. Rappold JF, Pusateri AE., Tranexamic acid in remote damage control resuscitation. Transfusion 2013; 53: 96S-9S.
50. Ausset S, Glassberg E, Nadler R, et al., Tranexamic acid as part of remote damage-control resuscitation in the pre-hospital setting: a critical appraisal of the medical literature and available alternatives. J Trauma Acute Care Surg 2015; 78: S70-5.
51. Mosesson MW., Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-904.
52. Fries D, Martini WZ., Role of fibrinogen in trauma-induced coagulopathy. Brit J Anaesthesia 2010; 105: 116-21.
53. Spahn D., Severe bleeding in surgical and trauma patients: the role of fibrinogen replacement therapy. Thromb Res 2012; S14-9.
54. Sorensen B, Larsen OH, Rea C, et al., Fibrinogen as a hemostatic agent. Semin Thromb Hemost 2012; 38: 268-73.
55. Korte W., Fibrin monomer and factor XIII: a new concept for unexplained intraoperative coagulopathy. Hämostaseologie 2006; 26: S30-5.
56. Sorensen B, Tang M, Larsen O, et al., The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding. Thromb Res 2011; 128 Suppl 1: S13-6.
57. Hiippala ST, Myllylä GJ, Vahtera EM., Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5.
58. Levy J, Welsby I, Goodnough L., Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014; 54: 1389-405.
59. Floccard B, Rugeri L, Faure A, et al., Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012; 43: 26-32.
60. Deras P, Villiet M, Manzanera J, et al., Early coagulopathy at hospital admission predicts initial or delayed fibrinogen deficit in severe trauma patients. J Trauma Acute Care Surg 2014; 77: 433-40.
61. Hess J, Lindell A, Stansbury L, et al., The prevalence of abnormal results of conventional coagulation tests on admission to a trauma center. Transfusion 2009; 49: 34-9.
62. Hagemo J, Stanworth S, Juffermans N, et al., Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multi-center observational study. Crit Care 2014; 18: R52.
63. Rourke C, Curry N, Khan S, et al., Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10: 1342-51.
64. Inaba K, Karamanos E, Lustenberger T, et al., Impact of fibrinogen levels on outcomes after injury in patients requiring a massive transfusion. J Am Coll Surg 2013; 216: 290-7.
65. Kornblith L, Kutcher M, Redick B, et al., Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis. J Trauma Acute Care Surg 2014; 76: 255-6.
66. Meyer M, Sorensen A, Johansson P., Effect of fibrinogen concentrate on clot strength in trauma: preliminary results of an in vitro study. Scand J Trauma Resus Emerg Med 2012; 20: O2.
67. Harr J, Moore E, Ghasabyan A, et al., Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock 2013; 39: 45-9.
68. Curry N, Rourke C, Davenport R, et al., Early cryoprecipitate for major haemorrhage in trauma: a randomized controlled feasibility trial. Br J Anaesth 2015; 115: 76-83.
69. Schlimp C, Voelckel W, Inaba K, et al., Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study. Scand J Trauma Resusc Emerg Med 2013; 21: 74.
70. Fenger-Eriksen C, Lindberg-Larsen M, Christensen A, et al., Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008; 101: 769-73.
71. Ponschab M, Voelckel W, Pavelka M, et al., Effect of coagulation factor concentrate administration on ROTEM parameters in major trauma. Scand J Trauma Resusc Emerg Med 2015; 23: 84.
72. Schöchl H, Nienaber U, Maegele M, et al., Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83.
73. Schlimp C, Voelckel W, Inaba K, et al., Estimation of plasma fibrinogen levels based on hemoglobin, base excess and injury severity score upon emergency room admission. Crit Care 2013; 17: R137.
74. ClinicalTrials.gov. Fibrinogen Concentrate (FGTW) in trauma patients presumed to bleed (FI in TIC). Available from: http://clinicaltrials.gov.show/NCT0145344
75. Maegele M, Zinser M, Schlimp C, et al., Injectable hemostatic adjuncts in trauma: fibrinogen and the FIinTIC study. J Trauma Acute Care Surg 2015; 78: S76-82.
76. Fenger-Eriksen C, Jensen T, Kristensen B, et al., Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7: 795-802.
77. Karlson M, Termström L, Hyllner M, et al., Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery: a prospective randomised pilot study. J Thromb Haemost 2009; 102: 137-44.
78. Schöchl H, Voelckel W, Maegele M, et al., Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit Care 2014; 18: R147.
79. Zentai C, Braunschweig T, Schnabel J, et al., Fibrinogen concentrate does not suppress endogenous fibrinogen synthesis in a 24-hour porcine trauma model. Anaesthsiology 2014; 121: 753-64.
80. Fries D, Krismer A, Klingler A, et al., Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 2005; 95: 172-7.
81. Grottke O, Braunschweig T, Henzler D, et al., Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury. Crit Care 2010; 14: R62.
82. Morrison J, Ross J, Dubose J, et al., Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II study. JAMA Surg 2013; 148: 218-25.
83. Kashuk J, Moore E, Wohlauer M, et al., Initial experiences with point-of-care rapid thrombelastography for management of life-threatening post injury coagulopathy. Transfusion 2012; 52: 23-33.
84. Schick K, Fertmann J, Jauch K, et al., Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 2009; 13: R191.
85. Ferreira J, De Los Santos M., The clinical use of prothrombin complex concentrate. J Emerg Med 2013; 44: 1201-10.
86. American College of Surgeons Committee on Trauma: ATLS Student Manual. 9th ed. Chicago, IL: American College of Surgeons; 2012.